British chipmaker Arm (ARM) debuted on the public markets on Thursday, opening at $56.10 on the Nasdaq in afternoon trading.
Maksim Labkouski Talaris Therapeutics (NASDAQ:TALS) said its shareholders have approved its merger with Tourmaline Bio and a reverse stock split